Skip to content
Search

Latest Stories

Pharmacy bodies launch joint election manifesto, urge candidates to back a six-point plan

Pharmacy bodies launch joint election manifesto, urge candidates to back a six-point plan

Pharmacy owners and LPCs are encouraged to actively engage with candidates, ensuring that the voice of community pharmacy is heard ahead of the election.   

Community Pharmacy England (CPE), the Company Chemists’ Association (CCA), the Royal Pharmaceutical Society (RPS) and the National Pharmacy Association (NPA) on Tuesday (5 March) released a joint manifesto for community pharmacy in anticipation of the upcoming general election expected later this year.


The manifesto has been designed for widespread use within the community pharmacy sector to facilitate engagement with political parties and parliamentary candidates.

In their #VotePharmacy manifesto, the pharmacy bodies have highlighted a robust six-point plan to unleash the potential of pharmacy.

Election candidates are urged to express their support in six key areas, which include:

  1. Filling the funding gap and committing to long-term sustainable funding to empower pharmacies to deliver more NHS care.
  2. Enhancing the community pharmacy workforce to ensure they can meet the evolving needs of patients.
  3. Conducting a comprehensive review of the medicines supply chain to ensure that patients can readily access the medications they require.
  4. Implementing an enhanced Pharmacy First service for England, based on the successful models in Scotland and Wales.
  5. Establishing an ambitious roadmap for independent prescribing to empower community pharmacists to do more.
  6. Making pharmacies focal points for public health, prevention and reducing health inequalities.

“The general election campaigning period is always an important moment to highlight community pharmacies – both their value and the critical situation they now find themselves in – and to start to build Parliamentary supporters for the future,” said CPE chief executive, Janet Morrison.

She expressed that the manifesto strongly aligns with the ongoing demand for investment and support that CPE is actively pursuing, and it will help in advancing their efforts in that direction.

She urged all pharmacy owners, local pharmaceutical committees (LPCs), and other pharmacy owner representatives to support the manifesto and help “make community pharmacy’s voice heard ahead of the election.”

CCA chief executive, Malcolm Harrison, highlighted that years of underfunding have resulted in the loss of more than 1,000 pharmacies.

Although he acknowledged the launch of Pharmacy First as “a positive first step towards changing the future for pharmacy, he expressed concern that without additional investment in the core funding for medicines supply, the trend of closures might continue.

“Additional funding will help to protect patients’ access to medicines and NHS care, such as Pharmacy First.  Moreover, we want to see Pharmacy First enhanced and expanded at pace – doing so makes sense for patients, pharmacies and the NHS,” Harrison added.

Paul Rees, the chief executive of the NPA, emphasised the critical need for the next government, regardless of which party forms it, to recognise that community pharmacy is facing its “biggest crisis in living memory.”

He highlighted the alarming statistics of eight pharmacies closing weekly, and a total of 1,000 closed over the past decade.

Furthermore, he underscored the urgent need for a new deal for pharmacy, which must include a massive injection of funding and an end to community pharmacy being treated as a “second-class citizen” within the NHS, among other things.

Community pharmacy is viewed as “a way to squeeze out cost” instead of as a valued clinical service, he said.

“This joint manifesto spells out the many challenges requiring an urgent political response, to maximise our sector’s contribution to NHS patient care,” Rees added.

Tase Oputu, chair of the RPS England, reiterated the crucial role community pharmacy plays in caring for millions of patients each year, from boosting vaccine uptake to tackling health inequalities and ensuring vital access to medicines.

Nevertheless, she remarked that the system is currently under pressure, and it is imperative to secure sustainable funding and support for the workforce.

“As more pharmacists become prescribers, it is vital the next government makes the most of this opportunity to transform patient care and ensure a positive future for community pharmacy at the heart of the nation’s health service,” she said.

Pharmacy teams are encouraged to actively engage with candidates, utilising this manifesto and accompanying resources as well as practical advice available through the online general election hub (www.votepharmacy.org).

More For You

RPS backs Pharmacist Support "Gift in Wills" initiative

The ‘Gift in Wills’ initiative is delivered in partnership with Bequeathed.

Photo credit: gettyimages

Leave a legacy: RPS partners with Pharmacist Support to promote ‘Gift in Wills’

The Royal Pharmaceutical Society (RPS) has announced its support for the ‘Gift in Wills’ initiative run by Pharmacist Support, coinciding with the charity’s birthday celebrations today (Tuesday 15 April).

This collaboration allows RPS members to create a free will while also helping to safeguard the future of vital support services for the pharmacy profession.

Keep ReadingShow less
Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less